Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease Pedro Monteiro, Carlos Aguiar, Pedro Matos, José Silva-Nunes, Rita Birne, Patrícia Branco, Joaquim Calado, Miguel Melo, Jorge Polónia

Does lowering triglycerides reduce cardiovascular risk? José Pereira de Moura

Long-term effects of a cardiac rehabilitation program in the control of cardiovascular risk factors Sandra Magalhães, Maria Miguel Ribeiro, Ana Barreira, Preza Fernandes, Severo Torres, José Lopes Gomes, Sofia Viamonte